Sign In
Buy PRVCF
$0.0090
+0 (+0%)
At Close: Jun 03, 2026
PreveCeutical's Subsidiary, BioGene Therapeutics, Appoints President
07:00am, Wednesday, 13'th Nov 2024
Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that d
PreveCeutical Launches Strategic Partnership with BioGene Therapeutics
06:30am, Wednesday, 30'th Oct 2024
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that de
PreveCeutical Engages Phoenix Corporate Finance Inc. to Provide Advisory Services
02:46pm, Friday, 18'th Oct 2024
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that d
PreveCeutical Engages Outside The Box Capital Inc. to Provide Marketing Services
07:00am, Tuesday, 03'rd Sep 2024
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it has entered i
Preveceutical Announces Revocation of Management Cease Trade Order
07:00am, Tuesday, 09'th Jul 2024
Vancouver, British Columbia--(Newsfile Corp. - July 9, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that, further
PreveCeutical Provides Update on Management Cease Trade Order
06:17pm, Friday, 28'th Jun 2024
Vancouver, British Columbia--(Newsfile Corp. - June 28, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that today it
PreveCeutical Enters into Loan Agreements
04:22pm, Monday, 17'th Jun 2024
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that it has entered into a
PreveCeutical Provides Update on Management Cease Trade Order
07:00am, Friday, 14'th Jun 2024
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect
PreveCeutical Commences Litigation Against Former Legal Counsel in the British Columbia Supreme Court Alleging Professional Negligence
07:00am, Thursday, 06'th Jun 2024
Vancouver, British Columbia--(Newsfile Corp. - June 6, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it, along with cert
Preveceutical Provides Update on Management Cease Trade Order
07:00am, Thursday, 30'th May 2024
Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect
Preveceutical Announces First Tranche Closing of Private Placement
07:11pm, Wednesday, 29'th May 2024
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that further t
PreveCeutical Provides Update on Management Cease Trade Order
08:32pm, Thursday, 16'th May 2024
Vancouver, British Columbia--(Newsfile Corp. - May 16, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect t
PreveCeutical Announces Management Cease Trade Order
06:36pm, Thursday, 02'nd May 2024
Vancouver, British Columbia--(Newsfile Corp. - May 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company has misse
PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM
07:00am, Monday, 04'th Dec 2023
VANCOUVER, BC , Dec. 4, 2023 /PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparation
VANCOUVER, BC , Sept. 18, 2023 /PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is proud to announce that Endosane Pharmaceuticals
